Founder relief
US-Dutch medical device company EndoStim, developer of neurostimulation therapy for gastroesophageal reflux disease, has named Rohan Hoare as president and CEO. He succeeds founder Bevil Hogg, who will continue to serve the company as a consultant.
Hoare, who holds a Master of Arts and a PhD in physics from Harvard University, was previously president of the Neuromodulation business unit of Livanova, the London-based company formed by the merger of Cyberonics and Sorin Group.
NOD-Proteindesign.Andreas Heddergott/TUM.jpg
Certest
Consilium